Ahad Ashrafi-Asgarabad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ahad Ashrafi-Asgarabad has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Saeid Safiri
Managerial Epidemiology Research Center, Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, Islamic Republic of Iran; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
16 shared publications- Saeid Safiri
Research Center for Integrative Medicine in Aging, Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran
7 shared publications Erfan Ayubi
Department of epidemiology, School of public health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publicationsAhmad Kousha
Department of Health Education and Promotion, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publicationAhmad Naghibzadeh-Tahami
Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication- Ali Akbar Haghdoost
Kerman University of Medical Sciences
1 shared publication
Latest Publications
- Open Access
- 1 April 2024
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 28 (2) , 67-74
Investigating Characteristics of Hydatid Cyst Patients Referred to Health Centers in Kerman City, Iran
Objectives: Hydatid cysts are one of the most critical parasitic infections common to humans and animals and affect the health of communities. This study investigates the frequency distribution of hydatid cysts based on clinical and individual characteristics of patients referred to health centers in Kerman City, Iran, from 2011 to 2020. Methods: In this cross-sectional study, information was obtained from the medical records of 115 patients with hydatid cysts who were referred to hospitals and health centers during the years 2011-2020. Public and private clinics in Kerman City, Iran, were selected, and information on demography, and clinical and diagnostic approaches of patients were collected. Data analysis was performed using the SPSS software, version 22. Results: A total of 115 with a mean age of 20.31±0.89 years were included in the study. The highest number of patients was identified in 2013. More than half of the patients (53%) were female and the rest were male (47%). The age group of 20 to 40 years showed the highest rate of involvement (45.2%) while the age group of 60 to 80 years showed the lowest rate of involvement (1.3%). The majority of patients (76.5%) lived in the city and more than a quarter of patients had a history of contact with dogs (26.1%). Nausea (91.3%), chest pain and cough (46.1%), abdominal pain, and an enlarged liver (29.6%), were the most common clinical symptoms, and lungs (56.5%) and liver (31.3%) were the most involved organs in individuals. The disease was diagnosed by radiology and surgery in less than half of the patients (46.9%). Most patients (80%) received surgical and drug treatment together and the duration of treatment in less than half of them (45.2%) was two months. Discussion: The occurrence of hydatid cysts in Kerman City, Iran, especially in young people, is significant and the mean age of patients in Kerman City, similar to studies in some parts of the country, is very low, emphasizing the crucialness of being attentive to the disease and highlights the need for further research. Also, educating and informing families about the disease and its means of transmission along with controlling stray dogs can be beneficial in breaking the transmission chain.
- 1 April 2024
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 28 (2) , 67-74
Open AccessInvestigating Characteristics of Hydatid Cyst Patients Referred to Health Centers in Kerman City, Iran
Objectives: Hydatid cysts are one of the most critical parasitic infections common to humans and animals and affect the health of communities. This study investigates the frequency distribution of hydatid cysts based on clinical and individual characteristics of patients referred to health centers in Kerman City, Iran, from 2011 to 2020. Methods: In this cross-sectional study, information was obtained from the medical records of 115 patients with hydatid cysts who were referred to hospitals and health centers during the years 2011-2020. Public and private clinics in Kerman City, Iran, were selected, and information on demography, and clinical and diagnostic approaches of patients were collected. Data analysis was performed using the SPSS software, version 22. Results: A total of 115 with a mean age of 20.31±0.89 years were included in the study. The highest number of patients was identified in 2013. More than half of the patients (53%) were female and the rest were male (47%). The age group of 20 to 40 years showed the highest rate of involvement (45.2%) while the age group of 60 to 80 years showed the lowest rate of involvement (1.3%). The majority of patients (76.5%) lived in the city and more than a quarter of patients had a history of contact with dogs (26.1%). Nausea (91.3%), chest pain and cough (46.1%), abdominal pain, and an enlarged liver (29.6%), were the most common clinical symptoms, and lungs (56.5%) and liver (31.3%) were the most involved organs in individuals. The disease was diagnosed by radiology and surgery in less than half of the patients (46.9%). Most patients (80%) received surgical and drug treatment together and the duration of treatment in less than half of them (45.2%) was two months. Discussion: The occurrence of hydatid cysts in Kerman City, Iran, especially in young people, is significant and the mean age of patients in Kerman City, similar to studies in some parts of the country, is very low, emphasizing the crucialness of being attentive to the disease and highlights the need for further research. Also, educating and informing families about the disease and its means of transmission along with controlling stray dogs can be beneficial in breaking the transmission chain.
- 1 February 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (6) , 1224-1233
Serum Hepcidin, the Hepcidin/Ferritin Ratio and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
Objectives: To perform a meta-analysis on the relationship type 2 diabetes has with serum hepcidin and the hepcidin/ferritin ratio. Methods: The following databases were searched using all relevant keywords: Web of Science, Medline, Scopus, Embase and Google Scholar. All studies that examined the relationship type 2 diabetes has with serum hepcidin or the hepcidin/ferritin ratio were included in this meta-analysis and systematic review provided, were published in English between 2011 and 2018. A random-effects model was used to pool the standardized mean difference (SMD). Results: The SMD of serum hepcidin among patients with type 2 diabetes and healthy controls were compared across eight studies (n cases=878; n controls=2306). The pooled SMD of serum hepcidin did not differ significantly between study groups (SMD: 0.04; 95% confidence interval (CI): -0.29 to 0.35). In contrast, the serum hepcidin/ferritin ratio was examined across five studies (n cases=229; n controls=1426) and was found to be negatively associated with the risk of type 2 diabetes (SMD: -0.52; 95% confidence interval (CI): -0.85 to -0.19). There was no publication bias found for the associations serum hepcidin (Egger´s test: P =0.97) or the hepcidin/ferritin ratio (Egger´s test: P =0.75) had with type 2 diabetes. Conclusions: Although hepcidin has been proposed as a risk marker for type 2 diabetes, our metaanalysis found that the hepcidin/ferritin ratio was superior to hepcidin alone as a risk marker.
- 1 February 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (6) , 1224-1233
Serum Hepcidin, the Hepcidin/Ferritin Ratio and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
Objectives: To perform a meta-analysis on the relationship type 2 diabetes has with serum hepcidin and the hepcidin/ferritin ratio. Methods: The following databases were searched using all relevant keywords: Web of Science, Medline, Scopus, Embase and Google Scholar. All studies that examined the relationship type 2 diabetes has with serum hepcidin or the hepcidin/ferritin ratio were included in this meta-analysis and systematic review provided, were published in English between 2011 and 2018. A random-effects model was used to pool the standardized mean difference (SMD). Results: The SMD of serum hepcidin among patients with type 2 diabetes and healthy controls were compared across eight studies (n cases=878; n controls=2306). The pooled SMD of serum hepcidin did not differ significantly between study groups (SMD: 0.04; 95% confidence interval (CI): -0.29 to 0.35). In contrast, the serum hepcidin/ferritin ratio was examined across five studies (n cases=229; n controls=1426) and was found to be negatively associated with the risk of type 2 diabetes (SMD: -0.52; 95% confidence interval (CI): -0.85 to -0.19). There was no publication bias found for the associations serum hepcidin (Egger´s test: P =0.97) or the hepcidin/ferritin ratio (Egger´s test: P =0.75) had with type 2 diabetes. Conclusions: Although hepcidin has been proposed as a risk marker for type 2 diabetes, our metaanalysis found that the hepcidin/ferritin ratio was superior to hepcidin alone as a risk marker.
- 1 September 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (9) , e186-e187
Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller: Methodological Issues
- 1 September 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (9) , e186-e187
Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller: Methodological Issues
- 1 June 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (6) , 1721
Comments on “Short-Term Outcome of Spontaneous Intracerebral Hemorrhage in Algarve, Portugal: Retrospective Hospital-Based Study”
- 1 June 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (6) , 1721
Comments on “Short-Term Outcome of Spontaneous Intracerebral Hemorrhage in Algarve, Portugal: Retrospective Hospital-Based Study”
- 1 May 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (5) , e85-e86
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab: Methodological Issues
- 1 May 2018
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 13 (5) , e85-e86
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab: Methodological Issues
- 1 May 2018
- Published by Elsevier in The American Journal of Medicine
- Vol. 131 (5) , e209-E209
Methodological Issues in “Dietary Patterns and Long-Term Survival”
- 1 May 2018
- Published by Elsevier in The American Journal of Medicine
- Vol. 131 (5) , e209-E209
Methodological Issues in “Dietary Patterns and Long-Term Survival”
- Open Access
- 1 May 2018
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 117 (5) , 454-455
Comments on “Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center”
- 1 May 2018
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 117 (5) , 454-455
Open AccessComments on “Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center”